QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)

Avanos Medical - AVNS Stock Forecast, Price & News

$31.04
-0.55 (-1.74%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$31.02
$31.55
50-Day Range
$25.97
$31.75
52-Week Range
$19.32
$35.91
Volume
238,065 shs
Average Volume
232,178 shs
Market Capitalization
$1.44 billion
P/E Ratio
34.49
Dividend Yield
N/A
Price Target
$29.33

Avanos Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
5.5% Downside
$29.33 Price Target
Short Interest
Bearish
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.70mentions of Avanos Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.89%
From $1.52 to $1.64 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Medical Sector

822nd out of 1,027 stocks

Surgical Appliances & Supplies Industry

18th out of 23 stocks

AVNS stock logo

About Avanos Medical (NYSE:AVNS) Stock

Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Stock News Headlines

AVNS Avanos Medical, Inc.
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Avanos Medical, Inc. Announces Third Quarter 2022 Results
Avanos Medical (AVNS) Tops Q3 Earnings Estimates
Expert Ratings for Avanos Medical
Avanos Medical Enters Oversold Territory (AVNS)
See More Headlines
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Company Calendar

Last Earnings
11/02/2021
Today
2/06/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
4,555
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.33
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
-5.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$5.20 million
Pretax Margin
8.15%

Debt

Sales & Book Value

Annual Sales
$744.60 million
Cash Flow
$1.92 per share
Book Value
$26.23 per share

Miscellaneous

Free Float
45,531,000
Market Cap
$1.44 billion
Optionable
Optionable
Beta
0.90

Key Executives

  • Joseph F. Woody
    Chief Executive Officer & Executive Director
  • Michael C. Greiner
    SVP, Chief Financial & Transformation Officer
  • Lee Burnes
    Senior VP-Global Research & Development
  • Michelle Scharfenberg
    Senior VP, Chief Ethics & Compliance Officer
  • William D. Haydon
    Senior VP & General Manager-Pain Franchise













AVNS Stock - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View AVNS analyst ratings
or view top-rated stocks.

What is Avanos Medical's stock price forecast for 2023?

2 equities research analysts have issued 12-month price targets for Avanos Medical's shares. Their AVNS share price forecasts range from $26.00 to $34.00. On average, they predict the company's share price to reach $29.33 in the next year. This suggests that the stock has a possible downside of 6.5%.
View analysts price targets for AVNS
or view top-rated stocks among Wall Street analysts.

How have AVNS shares performed in 2023?

Avanos Medical's stock was trading at $27.06 at the beginning of the year. Since then, AVNS shares have increased by 15.9% and is now trading at $31.37.
View the best growth stocks for 2023 here
.

Are investors shorting Avanos Medical?

Avanos Medical saw a increase in short interest in the month of December. As of December 30th, there was short interest totaling 863,600 shares, an increase of 19.2% from the December 15th total of 724,600 shares. Based on an average daily trading volume, of 224,100 shares, the days-to-cover ratio is currently 3.9 days. Currently, 1.9% of the company's shares are short sold.
View Avanos Medical's Short Interest
.

When is Avanos Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our AVNS earnings forecast
.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) announced its earnings results on Tuesday, November, 2nd. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by $0.02. The firm had revenue of $184.10 million for the quarter, compared to the consensus estimate of $183.90 million. Avanos Medical had a net margin of 5.39% and a trailing twelve-month return on equity of 5.74%. During the same period in the prior year, the firm posted $0.21 earnings per share.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $1.45-$1.65 for the period, compared to the consensus earnings per share estimate of $1.51. The company issued revenue guidance of $815.00 million-$835.00 million, compared to the consensus revenue estimate of $824.62 million.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (1.19%), New York State Teachers Retirement System (0.19%), New York State Common Retirement Fund (0.12%), Allspring Global Investments Holdings LLC (0.12%), Exchange Traded Concepts LLC (0.08%) and Ziegler Capital Management LLC (0.07%). Insiders that own company stock include Gary Blackford and Patrick J Oleary.
View institutional ownership trends
.

How do I buy shares of Avanos Medical?

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $31.37.

How much money does Avanos Medical make?

Avanos Medical (NYSE:AVNS) has a market capitalization of $1.46 billion and generates $744.60 million in revenue each year. The company earns $5.20 million in net income (profit) each year or $0.90 on an earnings per share basis.

How many employees does Avanos Medical have?

The company employs 4,555 workers across the globe.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com.

This page (NYSE:AVNS) was last updated on 2/6/2023 by MarketBeat.com Staff